Trypsinogen of mammalian species including man (Rinderknecht and Geokas, 1973) occurs in two variants differing slightly from one another in their biochemical properties such as isoelectric point, susceptibility to inhibitors, substrate specificity, and so on. Robinson et al. (1972) recently analysed pure pancreatic juice (PPJ) from 34 patients free of pancreatic disease and found that pancreatic secretions of different subjects contained either both or only one of the two trypsinogen variants. The authors suggested that the occurrence of two species of trypsinogen at different frequencies in different segments of the population may represent a genetically determined polymorphism of this zymogen. In view of the important function of trypsin as activator of Received for publication 26 April 1979 pancreatic zymogens and its putative role in the pathogenesis of pancreatitis and pancreatic malignancy (White and Allan, 1974) , we decided to investigate the possibility of a correlation between the frequency pattern of trypsinogen variants and the incidence of pancreatic disease. The work presented here describes the distribution of trypsinogen variants in PPJ of normal, healthy subjects, chronic alcoholics, patients with pancreatitis, and gives a preliminary account of the trypsinogen variants in PPJ of two patients with cancer of the pancreas. Alcoholics were included in this investigation because of the possibility that alcohol abuse, one of the main aetiological factors in pancreatitis and possibly cancer of the pancreas (Burch and Patients with cancer ofpancreas Some 30 patients with cancer of the pancreas were subjected to ERP. Although this procedure was successful diagnostically in most cases, only two patients furnished satisfactory secretory profiles. Obstruction of the pancreatic duct by the tumour prevented collection of PPJ in some patients or pancreatic tissue no longer responded to stimulation by hormones in others. Cancer of the pancreas in one patient was diagnosed at the time of collection of PPJ by a grossly abnormal pancreatogram showing a stricture at the junction of body and tail of the pancreas. In the other patient who had a normal pancreatogram at the time of collection of PPJ, cancer of the pancreas was diagnosed at necropsy by histology.
COLLECTION PROCEDURE
Pure pancreatic juice was obtained by cannulation of the main pancreatic duct as described by Rinderknecht et al. (1978b) . Secretions were collected at one minute intervals for a total of 20 minutes after initial stimulation with secretin and cholecystokininpancreozymin (CCK-PZ) 10 minutes later. Samples were assayed immediately or stored at -70°C. The procedure was explained in detail to volunteers and patients and informed consent obtained from each individual. The protocol was approved by the VA Human Studies Subcommittee and LAC-USC Medical Center Human Research Committee.
A SSAY S Trypsinogen present in each of the one minute collections of PPJ was determined as active trypsin after activation with human enteropeptidase as described previously (Rinderknecht et al, 1978b) . Trypsin activity is expressed in ,ug active site-titrated bovine trypsin/ml PPJ. One ,ug active-site titrated trypsin equals 70 mIU. Trypsin (Worthington Biochemical Corp., Freehold, N J) is about 55-60% active. Pancreatic trypsin inhibitor was determined according to Rinderknecht et al. (1978b) . ELECTROPHORESIS Gels containing 8.5 % polyacrylamide and measuring 10.5 cm were prepared in siliconised tubes 0.7 cm in diameter. Acrylamide was dissolved in buffer containing 0.2 mol/l glycine, 0.05 mol/l Tris, and 0.001 mol/l EDTA and the solution was adjusted to pH 8.2. After polymerisation with tetramethylethylenediamine and ammonium persulphate, excess persulphate was removed by pre-electrophoresis.
Pure pancreatic juice (50-100 ,ul of the one minute collection showing the highest concentration of trypsinogen after CCK-PZ administration) was placed on the gel and subjected to electrophoresis at Figure also shows an additional minor component with trypsinogen-like properties. As an active enzyme (enzyme-X) it is, however, not inhibited by human or Kunitz bovine pancreatic trypsin inhibitor as shown on the right hand side of Fig. 1 (Rinderknecht et al. 1978a) . Figure 2A illustrates a typical profile of the two trypsinogens in PPJ of chronic alcoholics. It can be seen that, in these patients, in contrast with normal subjects, the predominant zymogen is the anionic variant. Profiles of patients with pancreatitis or cancer of the pancreas also exhibited a preponderance of anionic trypsinogen (Fig. 2, B and C).
The reproducibility of such profiles was found to be quite satisfactory, particularly in view of the Zymogens measured as active site-titrated bovine trypsin as described in the section on Methods. Left: C= cationic trypsinogen, X= zymogen of enzyme-X, A=anionic trypsinogen. Right: activity determined in the presence of 2 KIU Trasylol. (Rinderknecht and Fleming, 1975) were detected occasionally as contaminant of part of the cationic trypsin peak, but they had no effect on the trypsin determinations. No chymotrypsin was found in the anionic trypsin or enzyme-X peak of the electrophoretic profile.
Human pancreatic juice contains two trypsin inhibitors. The larger, less anionic component was found to be located, at least partially, below the cationic trypsinogen peak, the smaller variant in the area of enzyme-X. Because the relative proportions of the two inhibitors could not be measured for each individual and are capable of inhibiting only a minor part of the total potential trypsin activity, they were omitted from consideration in the following calculations. Table 1 sinogen variants in the patient groups is particularly striking when expressed as the ratio of cationic to anionic trypsinogen. This ratio without exception was above 1 in normal subjects and below 1 in chronic alcoholics. All but one of the pancreatitis patients showed a ratio below 1. The patients with cancer of the pancreas exhibited particularly low ratios, as seen in Table 1 .
The mean concentration of the minor component zymogen-X discovered by us in PPJ (Rinderknecht et al., 1978a ) was higher than normal in chronic alcoholics, but below normal in patients with pancreatitis and extremely low in patients with cancer of the pancreas, These differences were statistically significant.
Discussion
The results of our investigation clearly demonstrate the presence of two trypsinogen variants in PPJ of every individual tested and thus are at variance with the concept of a genetic polymorphism of this zymogen with an uneven distribution in the population as postulated by Robinson et al. (1972) . The discrepancy in these findings may be due to differences in methodology and in the type of pancreatic secretion used for investigation. Whereas Robinson and co-workers used basal PPJ, we studied secretions obtained at peak stimulation with cholecystokininpancreozymin.
In normal non-alcoholic individuals cationic trypsinogen invariably was the more abundant of the two variants. It constituted about 650% of the total trypsin activity as measured by our method. The same proportion of this zymogen in human PPJ has been reported recently by Guy et al. (1978) . However, our findings indicate that the ratio of cationic to anionic trypsinogen, normally close to 2, is very labile and susceptible to reversal to a value of less than 1 by as yet undefined biochemical changes in pancreatic tissue. Such changes apparently result from the prolonged action of ethanol and probably other noxious agents or conditions associated with pancreatitis and cancer of the pancreas. Table 1 shows that the change of this ratio in chronic alcoholics is attributable to a highly significant, selective increase (about six-fold over normal) of anionic over cationic trypsinogen and not to a decrease of the cationic variant. In the group of pancreatitis patients with a mean ratio: cationic to anionic trypsinogen of 0.45, anionic trypsinogen also showed an increase above the normal level, but this finding lacked statistical significance. Cationic trypsinogen on the other hand was significantly decreased in this group. It must be emphasised that these results reflect a trend in a grossly heterogeneous group of patients. Classification of the patients into groups according to the stage of their disease might, in a much larger study, refine the data to correspond more accurately with the clinical condition of the patients. In both patients with cancer of the pancreas, the anionic species of trypsinogen remained in the low normal range and the decrease in the ratio: cationic to anionic trypsinogen to less than 1 was due exclusively to a reduction of the cationic variant.
The mechanism involved in the increased secretion of anionic vs. cationic trypsinogen in PPJ of our patient groups is unknown. The high recovery rate of trypsinogen applied in the electrophoretic analyses certainly seems to preclude selective destruction of the cationic variant in our procedure. Elsewhere (Renner et al., 1978) , we reported that the mean flow rate of pancreatic juice after sequential stimulation with secretin and cholecystokinin-pancreozymin was similar for normal subjects and chronic alcoholics-that is, 3.26 ml vs. 3.31 ml/min-and that the concentrations of chymotrypsinogen, proelastase, as well as trypsin inhibitor, were increased slightly in alcoholics without, however, reaching statistical significance. The increase in trypsinogen concentration, on the other hand, was highly significant as illustrated also in Table 1 . Therefore, the most acceptable explanation for our findings is selective stimulation of the gene coding for anionic trypsinogen and increased synthesis of this species compared with that of the cationic variant in chronic alcoholics. The preponderance of anionic over cationic trypsinogen in PPJ of patients with cancer of the pancreas or pancreatitis could be explained on the same basis. Whereas the concentration of cationic trypsinogen (Table 1) , chymotrypsinogen, proelastase and trypsin inhibitor in our patients with cancer of the pancreas was below normal (unpublished results) reflecting reduced secretory capacity of the pancreas, the level of anionic trypsinogen remained in the normal range. The heterogeneous group of patients with pancreatitis, most of whom were alcoholics, exhibited enzyme profiles varying between those of chronic alcoholics without pancreatic disease and those of the cancer patients. Although increased release of anionic trypsinogen due to greater sensitivity to CCK-PZ in the patient groups must be considered also as a potential factor in this mechanism, the concept of a faster release of one variant relative to the other is not in accord with the data given in Table 2 . However, the accuracy of the complex procedure for the determination of the ratio of zymogens may well not be high enough to detect the increase in ratio with time that would be expected from such a mechanism. Our observations suggest that detection of a ratio of cationic/anionic tryp-sinogen of less than 1 in PPJ may be a sensitive indicator of incipient or established pancreatic pathology. Investigations of the effect of biliary disease, as well as various medications thought to be associated with the development of pancreatitis, are in progress and should shed additional light on this hypothesis. Determination of the minimum level of alcohol intake required for induction of anionic trypsinogen will also be of great interest.
The potential role and significance of increased concentrations of anionic trypsinogen in the pathogenesis of pancreatic disease is open to speculation. Louvard and Puigserver (1974) recently reported that the anionic form of bovine and porcine trypsinogen is activated more readily by enteropeptidase than the cationic variant, but this does not necessarily pertain to other enzymes which might be more likely to be involved in intrapancreatic activation of trypsinogen than enteropeptidase. However, should this analogy be valid, it would seem plausible that greatly raised concentrations of anionic trypsinogen with an increased susceptibility to activation in the presence of only normal (Renner et al., 1978) or even decreased levels of inhibitor might severely compromise an important defence mechanism against premature activation of zymogens in the pancreas of subjects thus affected. Reduced concentrations of trypsin inhibitor observed by us in some patients with pancreatitis and cancer of the pancreas (unpublished results) tend to support this view.
It is of interest here to note that the secretion of the zymogen of enzyme-X was increased significantly in chronic alcoholics, but decreased markedly in patients with pancreatitis (Table 1) or cancer of the pancreas. The identity of this enzyme has not been fully extablished (Rinderknecht et al., 1978a) and clarification of its role in pancreatic physiology and pathophysiology must await further research. 
